Maasstad ziekenhuis

Rotterdam 3079DZ

2 studies enrolling now · 9 studies all time

What they study most

Atherosclerosis, Carcinoma, Non-Small-Cell Lung, Community-acquired Pneumonia, Influenza, COVID-19, Coronary Artery Disease, Coronary Artery Stenosis, Coronary Heart Disease (CHD), Heart Failure With Left Bundle Branch Block, Multiple Myeloma

Studies at this site

• Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation — Recruiting now
• Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia — Recruiting now
• Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke — Completed
• PIONEER III Trial to Assess Safety and Efficacy of the BuMA Supreme™ Drug Coated Coronary Stent in Patients With Coronary Disease — Completed
• AdaptResponse Clinical Trial — Completed
• Study of BioNIR Drug Eluting Stent System in Coronary Stenosis — Completed
• A Study of Atezolizumab in Combination With Carboplatin Plus (+) Paclitaxel With or Without Bevacizumab Compared With Carboplatin+Paclitaxel+Bevacizumab in Participants With Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC) — Completed
• The Lipid-Rich Plaque Study — Completed
• Safety and Efficacy of Six Months Dual Antiplatelet Therapy After Drug-Eluting Stenting — Status unconfirmed